Clinical Trial Update: Safety and Tolerability of EO2002 [Phase 1]

View source ↗

Summary

Phase 1 trial update on EO2002 evaluating safety and tolerability in cataract and corneal endothelial disease. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Corneal Endothelial Disease

Drugs mentioned

• EO2002

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Cataract, Endothelial Cell Loss, Corneal | Phase 1 | Status: RECRUITING